A carregar...
The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
Breast cancer tumors that demonstrate gene amplification or overexpression of human epidermal growth factor receptor 2 (HER2) are classified as HER2-positive. They account for approximately 15% of all breast cancers and represent an adverse prognostic factor. Over the past years, many new therapies...
Na minha lista:
Publicado no: | Breast Cancer (Dove Med Press) |
---|---|
Main Authors: | , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445592/ https://ncbi.nlm.nih.gov/pubmed/26056489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S61579 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|